SCHEMBL5637526

SCHEMBL5637526

CC(C)(C)OC(=O)N1CC[C@H]2c3cc(-c4ccc(Cl)cc4Cl)cc4c3N(CCCS4)[C@H]2CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.55
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
CNR1 P21554 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CNR2 P34972 1/20 0.38
USP2 O75604 1/20 0.38
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
STS P08842 2/20 0.37
MAPT P10636 3/20 0.36
TP53 P04637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
DPP4 P27487 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5638128 1.00 HTR2C (0.55) HTR2CDRD2HTR2ACNR1MEN1
SCHEMBL5636180 0.94 HTR2C (0.54) HTR2CDRD2HTR2ACNR1MEN1
SCHEMBL5634987 0.94 HTR2C (0.54) HTR2CDRD2HTR2ACNR1MEN1
SCHEMBL5636200 0.91 HTR2C (0.45) HTR2CDRD2HTR2AMEN1KMT2A
SCHEMBL5637659 0.90 HTR2C (0.48) HTR2CDRD2HTR2ACNR1MEN1
SCHEMBL5636581 0.86 HTR2C (0.45) HTR2CDRD2HTR2A
SCHEMBL5636957 0.84 HTR2C (0.43) HTR2CDRD2HTR2A
SCHEMBL5635065 0.84 ALDH1A1 (0.40) HTR2CHTR2AMEN1KMT2AHPGD
SCHEMBL5636395 0.84 HTR2C (0.43) HTR2CDRD2HTR2AMEN1KMT2A
SCHEMBL15307683 0.83 HTR2C (0.69) HTR2CDRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US disclosed
US-6713471-B1 SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-03-30 US disclosed